Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.
about
Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)Current gene therapy for stomach carcinoma.Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.Gene therapy of gynaecological diseases.Study on the effect of BMSCs-EGFP-tk as mediator of HSV1-tk/GCV suicide gene therapy directed against A549 in vitroSuicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells.Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo.Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5.Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model.
P2860
Q34433546-EF3A7B50-2266-435A-878F-6E788B7F9042Q34512167-D4FC4E7A-2D24-4E70-8AC7-F8A24D466BEAQ35549847-1B5B1076-2376-4888-BC47-7ED7C5EFFDD3Q36922247-BEF26AD5-9400-4A47-977B-0A9A8BF18912Q39106111-25BFA3AA-DBBF-4F41-81A9-35DD32D73460Q40678035-501B3440-979B-424C-9F0A-FF621EF3DCA5Q43030471-627808F4-A4E3-4630-946D-711367BCCB02Q43873064-D724428A-7616-44F9-8813-CE49B9C6C61FQ43962720-89C651C4-FB09-4966-821C-313468DECD77Q43992111-9A403681-6697-43AF-B44D-6EA3BC530392Q44519499-D43D7623-1432-412D-A59E-0775AE7B13B0
P2860
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@ast
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@en
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@nl
type
label
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@ast
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@en
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@nl
prefLabel
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@ast
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@en
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@nl
P2093
P921
P356
P1433
P1476
Thymidine kinase gene therapy ...... for recurrent ovarian cancer.
@en
P2093
Aguilar-Cordova E
Hasenburg A
Kaufman RH
Kieback CC
Kieback DG
Nyberg-Hoffman C
Rojas-Martinez A
P2888
P304
P356
10.1038/SJ.CGT.7700192
P577
2000-06-01T00:00:00Z
P5875
P6179
1018559166